Procainamide

An article about the antiarrhythmic medication Procainamide

Chemical structure of Procainamide

Procainamide is a medication used to treat a variety of cardiac arrhythmias. It is classified as a Class A antiarrhythmic agent and works by blocking sodium channels in the heart, which helps to stabilize the cardiac membrane and reduce abnormal electrical activity.

Mechanism of Action

Procainamide works primarily by inhibiting the influx of sodium ions through the sodium channels during the depolarization phase of the cardiac action potential. This action prolongs the action potential duration and the effective refractory period of cardiac cells, particularly in the atria and ventricles. By doing so, it helps to suppress abnormal ectopic pacemaker activity and reentrant arrhythmias.

Clinical Uses

Procainamide is used in the management of several types of arrhythmias, including:

• Atrial fibrillation
• Atrial flutter
• Ventricular tachycardia
• Wolff-Parkinson-White syndrome

It is often administered intravenously in acute settings, especially in cases of life-threatening ventricular arrhythmias.

Side Effects

Common side effects of procainamide include:

• Hypotension
• Nausea
• Vomiting
• Rash

Serious side effects can include:

• Lupus-like syndrome
• Agranulocytosis
• QT interval prolongation

Pharmacokinetics

Procainamide is metabolized in the liver to N-acetylprocainamide (NAPA), which also has antiarrhythmic properties. The drug and its metabolite are excreted by the kidneys, and dose adjustments may be necessary in patients with renal impairment.

History

Procainamide was first introduced in the 1950s as an alternative to quinidine, another antiarrhythmic agent. It has since become a staple in the treatment of arrhythmias, particularly in emergency settings.

Related pages

• Antiarrhythmic agent
• Cardiac arrhythmia
• Sodium channel blocker